Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy

BACKGROUND: Chemotherapy efficacy in early-stage hormone receptor-positive (HR+) breast cancer (BC) according to menopausal status needs a biological explanation. METHODS: We compared early-stage HR+ BC biological features before and after (neo)adjuvant chemotherapy or endocrine therapy (ET), and as...

Descripción completa

Detalles Bibliográficos
Autores principales: Chic, Nuria, Schettini, Francesco, Brasó-Maristany, Fara, Sanfeliu, Esther, Adamo, Barbara, Vidal, Maria, Martínez, Débora, Galván, Patricia, González-Farré, Blanca, Cortés, Javier, Gavilá, Joaquín, Saura, Cristina, Oliveira, Mafalda, Pernas, Sònia, Martínez-Sáez, Olga, Soberino, Jesús, Ciruelos, Eva, Carey, Lisa A., Muñoz, Montserrat, Perou, Charles M., Pascual, Tomás, Bellet, Meritxell, Prat, Aleix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233691/
https://www.ncbi.nlm.nih.gov/pubmed/34161883
http://dx.doi.org/10.1016/j.ebiom.2021.103451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233691/
https://www.ncbi.nlm.nih.gov/pubmed/34161883
http://dx.doi.org/10.1016/j.ebiom.2021.103451

Ejemplares similares